Next, complete eradication of all detectable AML was only accomplished following treatment with IMAK, using maternal lymphocytes preactivated with IL-2 for 4 days prior to cell infusion and with subcutaneous injections of IL-2 for 3 days following cell infusion. Here, IL2 is linked to acute myeloid leukemia.